Early discontinuation of ribavirin in HCV-2 and HCV-3 patients responding to Peg-interferon alpha-2a and ribavirin.
Andriulli A, Cursaro C, Cozzolongo R, Iacobellis A, Valvano MR, Mangia A, Minerva N, Bacca D, Stanzione M, Scuteri A, Montalto G, Andreone P.
Andriulli A, et al. Among authors: scuteri a.
J Viral Hepat. 2009 Jan;16(1):28-35. doi: 10.1111/j.1365-2893.2008.01044.x. Epub 2008 Aug 28.
J Viral Hepat. 2009.
PMID: 18761603
Clinical Trial.